What Does Resistance to Targeted Therapy Mean? Targeted therapies for cancer are medicines designed to precisely target the protein that’s making your cancer grow. In the case of epidermal growth ...
Finding out you have epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC) is a shock for anyone. You’ll have a lot to process and learn about your cancer and how your ...
In the past several years, our understanding of lung cancer has become much more detailed and nuanced. "When I started [practicing medicine about 20 years ago], lung cancer was just small cell lung ...
Michelle Afkhami, MD, of City of Hope, joins The American Journal of Managed Care® (AJMC®) for a discussion on EGFR exon 20 insertion positive mutations in non-small cell lung cancer. Michelle Afkhami ...
BDTX centers its strategy on silevertinib, its only clinical asset in EGFR-mutant NSCLC. Silevertinib shows 60% ORR and 86% CNS response in Phase II non-classical EGFR NSCLC data. Black Diamond ...
Dr. Girindra Raval sat down for an interview with CURE to discuss what patients with EGFR-mutated lung cancer should know about their treatment options. Dr. Girindra Raval sat down for an interview ...
Cetuximab induces responses in about 13% of head and neck squamous cell carcinomas (HNSCC). We describe the molecular mechanism of acquired resistance to cetuximab, which could be overcome by ...
DelveInsight's EGFR Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results